BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34704360)

  • 1. Response and safety of whole-brain radiotherapy plus temozolomide for patients with brain metastases of non-small-cell lung cancer: A meta-analysis.
    Han J; Qiu M; Su L; Wu C; Cheng S; Zhao Z; Li D; Wang M; Tao W; Du S
    Thorac Cancer; 2021 Dec; 12(23):3177-3183. PubMed ID: 34704360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer.
    Xin Y; Guo W; Yang CS; Huang Q; Zhang P; Zhang LZ; Jiang G
    Cancer Med; 2018 Apr; 7(4):981-990. PubMed ID: 29516684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
    Tian J; Luo Y; Xiang J; Tang J
    J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis.
    Duan H; Zheng SY; Zhou T; Cui HJ; Hu KW
    Medicine (Baltimore); 2020 Jan; 99(5):e18455. PubMed ID: 32000358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Whole brain radiation therapy plus temozolomide in the treatment of brain metastases from non small cell lung cancer: a meta-analysis].
    Liao K; Bi ZF; He Y; Liu YM
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(45):3199-203. PubMed ID: 23328466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastases.
    Zhu Y; Fu L; Jing W; Guo D; Kong L; Yu J
    Thorac Cancer; 2018 Sep; 9(9):1121-1128. PubMed ID: 29947170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
    Sperduto PW; Wang M; Robins HI; Schell MC; Werner-Wasik M; Komaki R; Souhami L; Buyyounouski MK; Khuntia D; Demas W; Shah SA; Nedzi LA; Perry G; Suh JH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1312-8. PubMed ID: 23391814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of WBRT+EGFR-TKI versus WBRT only in the treatment of NSCLC patients with brain metastasis: An updated meta-analysis.
    Zhou K; Cai X; Wang X; Lan X; Zhang X
    Thorac Cancer; 2022 Feb; 13(4):563-570. PubMed ID: 34970851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
    Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
    BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effectiveness of whole-brain radiotherapy plus temozolomide versus whole-brain radiotherapy in treating brain metastases based on a systematic review of randomized controlled trials.
    Bai GR; An JB; Chu Y; Wang XY; Li SM; Yan KJ; Lü FR; Gu N; Griffin AN; Sun BY; Li W; Wang GC; Zhou SP; Sun H; Liu CX
    Anticancer Drugs; 2016 Jan; 27(1):1-8. PubMed ID: 26426520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of synchronous stereotactic radiotherapy with temozolomide combined with whole brain radiotherapy in treating brain metastases originating from non-small cell lung cancer.
    Liu P; Ren R; You D; Liu J
    J BUON; 2020; 25(4):1771-1778. PubMed ID: 33099912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
    Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
    Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole brain reirradiation and concurrent temozolomide in patients with brain metastases.
    Minniti G; Scaringi C; Lanzetta G; Bozzao A; Romano A; De Sanctis V; Valeriani M; Osti M; Enrici RM
    J Neurooncol; 2014 Jun; 118(2):329-334. PubMed ID: 24718862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.
    Cao KI; Lebas N; Gerber S; Levy C; Le Scodan R; Bourgier C; Pierga JY; Gobillion A; Savignoni A; Kirova YM
    Ann Oncol; 2015 Jan; 26(1):89-94. PubMed ID: 25355723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.
    Qin H; Pan F; Li J; Zhang X; Liang H; Ruan Z
    PLoS One; 2014; 9(10):e111475. PubMed ID: 25347291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole brain radiotherapy plus chemotherapy in the treatment of brain metastases from lung cancer: a meta-analysis of 19 randomized controlled trails.
    Liu WJ; Zeng XT; Qin HF; Gao HJ; Bi WJ; Liu XQ
    Asian Pac J Cancer Prev; 2012; 13(7):3253-8. PubMed ID: 22994743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.
    Hassler MR; Pfeifer W; Knocke-Abulesz TH; Geissler K; Altorjai G; Dieckmann K; Marosi C
    Wien Klin Wochenschr; 2013 Aug; 125(15-16):481-6. PubMed ID: 23907204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?
    Schild SE; Behl D; Markovic SN; Brown PD; Sande JR; Deming RL; Rowland KM; Bearden JD
    Am J Clin Oncol; 2010 Dec; 33(6):633-6. PubMed ID: 20042969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
    Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
    Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by the graded prognostic assessment: A meta-analysis (PRISMA) of randomized control trials.
    Qie S; Li Y; Shi HY; Yuan L; Su L; Zhang X
    Medicine (Baltimore); 2018 Aug; 97(33):e11777. PubMed ID: 30113464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.